- Home
- TCRT vs EKSO Comparison
TCRT vs EKSO Comparison
Compare TCRT & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRT
- EKSO
- Stock Information
- Founded
- TCRT 1998
- EKSO 2005
- Country
- TCRT United States
- EKSO United States
- Employees
- TCRT N/A
- EKSO N/A
- Industry
- TCRT Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- TCRT Health Care
- EKSO Health Care
- Exchange
- TCRT Nasdaq
- EKSO Nasdaq
- Market Cap
- TCRT 7.0M
- EKSO 7.7M
- IPO Year
- TCRT N/A
- EKSO N/A
- Fundamental
- Price
- TCRT $2.84
- EKSO $5.09
- Analyst Decision
- TCRT
- EKSO Strong Buy
- Analyst Count
- TCRT 0
- EKSO 2
- Target Price
- TCRT N/A
- EKSO $34.75
- AVG Volume (30 Days)
- TCRT 1.3M
- EKSO 45.2K
- Earning Date
- TCRT 11-13-2025
- EKSO 10-24-2025
- Dividend Yield
- TCRT N/A
- EKSO N/A
- EPS Growth
- TCRT N/A
- EKSO N/A
- EPS
- TCRT N/A
- EKSO N/A
- Revenue
- TCRT $6,000.00
- EKSO $14,651,000.00
- Revenue This Year
- TCRT $5,680,500.00
- EKSO N/A
- Revenue Next Year
- TCRT N/A
- EKSO $49.96
- P/E Ratio
- TCRT N/A
- EKSO N/A
- Revenue Growth
- TCRT N/A
- EKSO N/A
- 52 Week Low
- TCRT $1.31
- EKSO $2.73
- 52 Week High
- TCRT $6.20
- EKSO $17.33
- Technical
- Relative Strength Index (RSI)
- TCRT 49.53
- EKSO 55.34
- Support Level
- TCRT $2.51
- EKSO $4.45
- Resistance Level
- TCRT $3.16
- EKSO $5.28
- Average True Range (ATR)
- TCRT 0.38
- EKSO 0.35
- MACD
- TCRT -0.07
- EKSO -0.08
- Stochastic Oscillator
- TCRT 16.02
- EKSO 58.18
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.